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A B S T R A C T
Reactive oxygen species (ROS) play a key role in development of heart failure but, at a cellular level, their eﬀects
range from cytoprotection to induction of cell death. Understanding how this is regulated is crucial to develop
novel strategies to ameliorate only the detrimental eﬀects. Here, we revisited the fundamental hypothesis that
the level of ROS per se is a key factor in the cellular response by applying diﬀerent concentrations of H2O2 to
cardiomyocytes. High concentrations rapidly reduced intracellular ATP and inhibited protein synthesis. This was
associated with activation of AMPK which phosphorylated and inhibited Raptor, a crucial component of mTOR
complex-1 that regulates protein synthesis. Inhibition of protein synthesis by high concentrations of H2O2
prevents synthesis of immediate early gene products required for downstream gene expression, and such mRNAs
(many encoding proteins required to deal with oxidant stress) were only induced by lower concentrations. Lower
concentrations of H2O2 promoted mTOR phosphorylation, associated with diﬀerential recruitment of some
mRNAs to the polysomes for translation. Some of the upregulated genes induced by low H2O2 levels are cyto-
protective. We identiﬁed p21Cip1/WAF1 as one such protein, and preventing its upregulation enhanced the rate of
cardiomyocyte apoptosis. The data support the concept of a “redox rheostat” in which diﬀerent degrees of ROS
inﬂuence cell energetics and intracellular signalling pathways to regulate mRNA and protein expression. This
sliding scale determines cell fate, modulating survival vs death.
1. Introduction
Heart failure, the end result of various progressive heart diseases, is
the leading cause of cardiovascular mortality in the developing world
[1]. The consequent inability of the heart to pump blood to the body is
associated with loss of terminally-diﬀerentiated contractile cardio-
myocytes, whether by necrosis (as occurs following myocardial in-
farction) or, if energy levels suﬃce, one of several forms of pro-
grammed cell death including apoptosis [2–4]. Enhancing
cardiomyocyte survival and reducing rates of cardiomyocyte death
would be therapeutically advantageous, but there are no clinical stra-
tegies yet available to achieve these aims.
Oxidative stress plays a pivotal role in modulating cardiomyocyte
survival, growth and death, but the eﬀects depend on the degree of
stress [5]. High levels of reactive oxygen species (ROS) are clearly da-
maging and result in unregulated cell death. More moderate levels in-
duce apoptosis through the mitochondrial death pathway with cleavage
and activation of caspases 9 and 3, and regulated dismantling of cellular
contents. In contrast, low ROS levels are associated with cardiomyocyte
survival and may even promote hypertrophy. These are examples of
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cellular responses by redox stress induced signalling, in which ROS
activate or inhibit intracellular redox-sensitive signal transduction
pathways [6–8]. ROS are produced either as a by-product of normal
cellular metabolism (e.g. mitochondrial leakage [9]) or by dedicated
ROS-producing enzymes (e.g. NADPH oxidases [10,11]). In either case,
H2O2, as a stable ROS moiety, is the predominant redox eﬀector [7],
and low-level H2O2 may be vital for upregulation of pro-survival and
cytoprotective genes [12].
Failing cardiomyocytes are energetically challenged and generate
less ATP [13,14]. This may be due in part to increased redox stress
signals. The mammalian target of rapamycin (mTOR) and AMP-acti-
vated protein kinase (AMPK) signalling pathways play a central role in
responding to ATP levels to modulate cardiomyocyte function [15,16].
mTOR, an evolutionarily conserved Ser/Thr protein kinase, operates in
one of two protein complexes, mTOR complex 1 (mTORC1) and
mTORC2 [17,18]. Of these, mTORC1 controls protein synthesis and
may particularly enhance expression of cytoprotective proteins, thereby
contributing to cell survival [19]. In contrast, AMPK is viewed as the
master regulator of energy homeostasis, being activated by nutrient-
poor conditions and increases in AMP associated with concomitant loss
of ATP [16]. AMPK inhibits mTORC1 via inhibitory phosphorylation of
an essential mTORC1 protein, Raptor, thus inhibiting protein synthesis.
Redox stress inhibits protein synthesis in cardiomyocytes [20], but the
mechanism is not fully understood.
Clearly, in cardiomyocytes (as in other cells), redox stress induced
signalling has a range of eﬀects on the cellular response and this could
be due to a number of factors including eﬀects of diﬀerent forms of ROS
[21] and/or localised ROS production to elicit redox signalling (e.g.
from NADPH oxidases or mitochondria [9–11]). Here, we revisited the
more fundamental hypothesis that the level of ROS stress per se is a key
factor in the cellular response. We applied diﬀerent concentrations of
H2O2 (as the most physiologically relevant form of ROS) globally to
cardiomyocytes, removing questions surrounding speciﬁc forms of
stressors or subcellular localisation. We focussed on the AMPK-mTOR
signalling axis and assessed the impact on expression of immediate
early genes (IEGs) and protein synthesis. We detected increased mTOR
signalling and induction of cytoprotective proteins such as p21Cip1/WAF1
with lower levels of oxidative stress, and inhibition of protein synthesis
with higher concentrations associated with cell death. Thus, quite apart
from considerations of ROS species and localisation, a “redox rheostat”
eﬀect operates in cells to elicit diﬀerent responses according to the
degree of stress.
2. Materials and methods
2.1. Cardiomyocyte isolation and culture conditions
Neonatal rat ventricular myocytes were dissociated from the ven-
tricles of 2 to 4 day Sprague-Dawley rat hearts as described previously
[22]. Cardiomyocytes were plated on Primaria culture dishes precoated
with 1% (v/v) gelatin for 18 h in Dulbecco's modiﬁed Eagle's medium
(DMEM)/M199 medium (4,1 ratio) containing 100 units/ml penicillin
and streptomycin plus 15% (v/v) foetal calf serum (FCS) at 37 °C. Un-
less otherwise stated, cells were plated at a density of 4× 106 cells per
60mm, 2 or 1.5× 106 (as indicated) cells per 35mm dish, or 3×105
cells/well in 24-well plates. Serum was withdrawn and cells incubated
in maintenance medium (DMEM/M199; 24 h). Cells were exposed to
H2O2 with or without 15 nM SU6656 (Calbiochem), 60 μM compound C
(Calbiochem) or 1 μM KU63794 (Selleck Chemicals). These inhibitors
were dissolved in DMSO and added directly to the medium (1/1000
dilution) before addition of H2O2.
2.2. Antisense oligodeoxynucleotide transfection
Serum-deprived cardiomyocytes in 35mm Primaria dishes were
exposed to phosphorothioate ﬂuorescein-tagged antisense
oligodeoxynucleotides (ODN, 200 nM; MWG, UK) corresponding to a
sequence encompassing the initiation codon of p21Cip1/WAF1 (p21Cip1/
WAF1AS, 5′_GACATCACCAGGATCGGACAT_3′) [23] or to 200 nM
scrambled ODN (5′_TGGATCCGACATGTCAGA_3′) derived from the
p21Cip1/WAF1 antisense (AS) sequence in serum-free DMEM containing
20 μg/ml lipofectin (Invitrogen). Cardiomyocytes were incubated for
24 h before addition of 0.2 mM H2O2 or 1 μM doxorubicin in DMSO.
2.3. Measurement of cardiomyocyte ATP concentrations
Cardiomyocytes in 24-well plates were incubated in 1ml DMEM/
M199 maintenance medium for 30min before exposure to H2O2. Cells
were scraped into 100 μl ice-cold 5% (v/v) perchloric acid and extracts
centrifuged (10,000×g, 5 min, 4 °C). Supernatants were diluted 1/10
in KTME buﬀer [100mM Tricine (pH 7.8), 10mM MgCl2, 2 mM EDTA,
1mM dithiothreitol] and duplicate samples (20 μl) were assayed. An
ATP standard curve (linear over the range of ATP used) was constructed
using ATP standards prepared in 5% (v/v) perchloric acid and diluted
1/10 in KTME buﬀer. Assays were initiated by addition of 100 μl KTME
buﬀer containing 1% (v/v) ﬁreﬂy lantern extract (Sigma FLE-250, re-
constituted at 10mg/ml in PBS) and 75 μM luciferin, and luminescence
measured using a TD-20/20 luminometer (Turner Designs) as light
emitted in 10 s following a 3 s delay.
2.4. Measurement of protein synthesis
Cardiomyocytes (2× 106 cells per 35mm dish) in maintenance
medium were incubated with H2O2 (2 h) with addition of L-
[2,3,4,5,6-3H]-phenylalanine ([3H]Phe, Perkin-Elmer) for the last 1 h of
the incubation as published [24]. Cardiomyocytes were washed in ice-
cold PBS (1ml) and scraped into 0.2mM NaOH (1ml). A sample (15 μl)
was taken to determine total protein using the Biorad Bradford method
[25]. Bovine serum albumin (0.1 ml, 100mg/ml) was added to the
remaining samples as a carrier, proteins were precipitated with 10%
(w/v) trichloroacetic acid (6ml) and centrifuged. Precipitates were
washed [10% (w/v) trichloroacetic acid (3× 5ml)], NaOH was added
(10 μl, 10M), and the pellets were dissolved in 1.8ml Soluene (Perkin-
Elmer, UK) before scintillation counting using Ultima Gold scintillation
ﬂuid (Perkin-Elmer, UK). Experiments were performed in duplicate, the
mean values were taken and corrected according to total protein. The
data are presented as means± SEM of these values. IC50 values for each
experiment were calculated using GraphPad Prism 7 software and the
mean of these values was taken.
2.5. Immunoblotting
Cardiomyocyte cell lysates were prepared as described previously
[22]. Brieﬂy, cardiomyocytes were washed in ice-cold PBS and scraped
into Buﬀer A [20mM β-glycerophosphate pH 7.5, 20mM NaF, 2mM
EDTA, 0.2 mM Na3VO4, 10mM benzamidine, 5 mM dithiothreitol,
300 μM phenylmethylsulfonyl ﬂuoride, 200 μM leupeptin, 2 μM micro-
cystin LR, 10 μM trans-epoxy-succinyl-L-leucylamido-(4-guanidino)-
butane] containing 1% (v/v) Triton X-100. Following centrifugation
(10,000×g, 5 min, 4 °C), the supernatants were boiled with 0.3 vol
sample buﬀer [10% (w/v) SDS, 13% (w/v) glycerol, 300mM Tris-HCl
pH 6.8, 130mM dithiothreitol, 0.2% (w/v) bromophenol blue]. For
isolation of the nuclear-enriched and cytosolic proteins, cells were
processed as published [26]. Proteins were separated by SDS-poly-
acrylamide gel electrophoresis and transferred to nitrocellulose mem-
branes. Proteins were detected with antibodies from Cell Signalling
Technologies Inc. [phosphorylated AMPK(Thr172) (cat. no.: 2535), total
AMPK (cat. no.: 2603), phosphorylated Raptor(Ser792) (cat. no.: 2083),
total Raptor (cat. no.: 2280), phosphorylated mTOR(Ser2448) (cat. no.:
2971), phosphorylated mTOR(Ser2481) (cat. no.: 2974), total mTOR
(cat. no.: 2983), phosphorylated PKB/Akt(Ser473) (cat. no.: 4060),
phosphorylated PKB/Akt(Thr308) (cat. no.: 2965), total PKB/Akt (cat.
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no.: 4691), cleaved caspase 3 (cat. no.: 9664)] all used at 1/1000 di-
lution except for cleaved caspase 3 antibodies that were used at 1/500.
Antibodies to p21Cip1/WAF1 were from Santa Cruz Biotechnology Inc.
(cat. no.: sc-471; 1/1000 dilution) or Upstate Biotech (supplied by
MERCK; cat. no. 05-345; 1/1000 dilution). Antibodies to sarcomeric α
actin were from Sigma (cat. no.: A-2172; 1/1000 dilution). Proteins
were detected by enhanced chemiluminescence using ECL Prime Wes-
tern Blotting detection reagents with visualisation using an ImageQuant
LAS4000 system (GE Healthcare). ImageQuant 7.0 software (GE
Healthcare) was used for densitometry.
2.6. RNA isolation, microarray analysis, ratiometric PCR and qPCR
Total RNA was prepared using RNA Bee (AMS Biotechnology Ltd)
according to the manufacturer's instructions. RNA was dissolved in
nuclease-free water and purity was assessed from the A260/A280 with
values of 1.8–2.1 (being considered acceptable). RNA concentrations
were determined from the A260. For microarray analysis, total RNA
(4× 106 cells per sample) and polysomal RNA (16× 106 cells per
sample) were prepared from control cardiomyocytes or cardiomyocytes
exposed to 0.2mM H2O2 (1 h) as described in [24]. RNAs were pre-
pared from 12 separate preparations of cardiomyocytes and individual
RNA samples were generated by combining equal amounts of RNA from
three separate myocyte preparations. Four sets of samples were hy-
bridised to individual Aﬀymetrix rat genome 230 2.0 microarrays.
cRNA preparations and microarray hybridizations were performed as
previously described [27]. Data (as CEL ﬁles) are available from Ar-
rayExpress (accession number: E-MTAB-6758).
The CEL ﬁles were imported into GeneSpring GX13 for analysis
using MAS 5.0 summarisation. Data were normalised to the gene
median and a conﬁdence ﬁlter applied (> 50 raw value). Probesets
were selected according to relative level of expression (> 1.5-fold in-
crease induced by H2O2 in total or polysomal RNA pools relative to
controls) followed by statistical testing (one-way ANOVA with SNK
post-test) using the Benjamini and Hochberg correction for multiple
testing [false discovery rate (FDR) < 0.05]. To identify mRNAs with
diﬀerential recruitment to polysomes, data for each RNA pool were
normalised to the median of the control values. Probesets were selected
with> 1.5-fold change induced by H2O2 in polysomes relative to total
RNA followed by statistical testing using a one-way ANOVA with SNK
post-test and with Benjamini and Hochberg FDR < 0.05.
First strand cDNA synthesis with oligo-dT priming and ratiometric
RT-PCR were performed as previously described [28] using primers for
p21Cip1/WAF1 (F1, 5′_ACTTTGACTTCGCCACTGAG_3′; F2, 5′_CTGCTAC
AGTGCCCGAGTTA_3′; F3, 5′_TCGTGGTACGGATCAGTGAT_3′; R1, 5′_
ACAGCAGAAGAAGGCGAGC_3′; R3, 5′_CAGAAGCGAGCTCTCG
GTA_3′), or glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
(sense primer: 5′-ACCACAGTCCATGCCATCAC-3′; antisense primer:
5′-TCCACCACCCTGTTGCTGTA-3′; 418 bp product). Samples were he-
ated (95 °C, 3min) and subjected to 22 or 28 cycles of denaturation
(95 °C, 50 s), annealing (61 °C, 50 s), and extension (72 °C, 50 s). Pro-
ducts were analyzed by ethidium bromide-agarose gel electrophoresis
[2% (w/v) agarose gels] and the bands captured under UV illumination.
Primer sets generated single products of the predicted sizes. Products
were analyzed by scanning densitometry and normalised to GAPDH
mRNA levels.
Quantitative PCR (qPCR) analysis was performed as previously de-
scribed [27]. Total RNA was reverse transcribed to cDNA by using High
Capacity cDNA Reverse Transcription Kits with random primers (Ap-
plied Biosystems) according to the manufacturer's instructions. qPCR
was performed using an ABI Real-Time PCR 7500 system (Applied
Biosystems). Optical 96-well reaction plates were used in parallel with
the iTaq Universal SYBR Green Supermix (Bio-Rad Laboratories Inc.)
according to the manufacturer's instructions. Primers were from Euro-
ﬁns [Atf3 (NM_012912.1): sense primer: 5′-TCGCCATCCAGAACAA
GCA-3′, antisense primer: 5′-GGGCCACCTCAGACTTGGT-3′, 108 bp
product; Cdkn1a (NM_080782.3): sense primer: 5′- CGGGACCGGGAC
ATCTC-3′, antisense primer: 5′- GGCACTTCAGGGCTTTCTCTT-3′,
106 bp product; Egr1 (NM_012551): sense primer: 5′- ACAACCCTACG
AGCACCTG-3′, antisense primer: 5′- GGATAACTTGTCTCCACCAG-3′,
84 bp product; Gapdh (NM_017008): sense primer: 5′- GCTGGCATTG
CTCTCAATGACA-3′, antisense primer: 5′- TCCACCACCCTGTTGCT
GTA-3′, 83 bp product; Hmox1 (NM_012580.2): sense primer: 5′- GAC
AGAGGAACACAAAGACCAGAGT-3′, antisense primer: 5′- GGTAGTAT
CTTGAACCAGGCTAGCA-3′, 82 bp product; Jun (NM_021835): sense
primer: 5′- GATCATCCAGTCCAGCAATG-3′, antisense primer: 5′- TAT
TCTGGCTATGCAGTTCAG-3′, 140 bp product; Mdm2
(NM_001108099.1): sense primer: 5′- TCCGACCACCGTGCTTCT-3′,
antisense primer: 5′- TCGGTAGACACAGACATGTTGGTA-3′, 69 bp pro-
duct; Nﬁl3 (NM_053727): sense primer: 5′- TGGGTCACAGCCATCC
GTT-3′, antisense primer: 5′- GCTTCAGCTTCTCGAATCCA -3′, 122 bp
product; Nqo1 (NM_017000.3): sense primer: 5′- GACATCACAGGGGA
GCCG-3′, antisense primer: 5′- CTCAGGCGGCCTTCCTTATAC-3′, 83 bp
product; Rasd1 (XM_340809.4): sense primer: 5′- GCGGCGAAGTCTAC
CAGTTG-3′, antisense primer: 5′- AAAACGTCTCCTGTGAGGATAG
AGA-3′, 94 bp product]. Relative quantiﬁcation was obtained using a
standard curve. Results were normalised to Gapdh mRNA levels, then to
controls or zero time.
2.7. Statistics
Data are presented as mean ± SEM of the results from at least 4
independent myocyte preparations as detailed in the ﬁgure legends.
Statistical analysis used one-way or two-way ANOVA with post-tests as
indicated (GraphPad Prism 7 software). Results were considered sta-
tistically signiﬁcant with p < .05.
3. Results
3.1. Redox stress reduces ATP concentrations and the rate of protein
synthesis
AMPK signalling, protein synthesis and apoptosis are intimately
linked to intracellular ATP concentrations [16]. To explore this re-
lationship in the context of redox stress induced signalling, we ex-
amined the eﬀects of H2O2 (a physiologically-relevant form of ROS) on
intracellular ATP concentrations in neonatal rat ventricular myocytes
(Fig. 1A). These cells are cultured from 2 to 4-day old rats to ensure that
the cells are post-mitotic. Though not completely representative of an
adult cardiomyocyte, they are an appropriate model for assessment of
general concepts of intracellular signalling in terminally-diﬀerentiated
cardiomyocytes. At H2O2 concentrations ≥0.1mM, ATP was rapidly
lost (> 50% reduction within 15min). At ≥1mM H2O2, intracellular
ATP was essentially completely lost within 30min, whereas at 0.1 mM
H2O2, ATP concentrations were reduced by 60–70% at 30min but
thereafter there was no further decrease (Fig. 1A). Integration of the
data in Fig. 1A showed that intracellular ATP concentrations were only
signiﬁcantly aﬀected above 0.03–0.1mM H2O2 with 50% of ATP being
lost over 2 h with ~0.08mM H2O2 (Fig. 1B). Protein synthesis requires
ATP. Increasing concentrations of H2O2 decreased cardiomyocyte pro-
tein synthesis rates over 2 h with an IC50 of ~0.55mM (Fig. 1C). This
was despite the fact that about 90% of the intracellular ATP content was
lost at this concentration of H2O2 (Fig. 1A). This suggests that the rate
of global protein synthesis is relatively resistant to loss of ATP.
3.2. Concentration-dependent eﬀects of H2O2 on phosphorylation and
activation of AMPK, mTOR and PKB/Akt, and on phosphorylation of the
mTORC1 component raptor
AMPK is a heterotrimer comprising a catalytic α subunit, a reg-
ulatory glycogen-binding β subunit, and a regulatory γ subunit which
binds adenine nucleotides, and detects increases in AMP and, to a lesser
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extent, ADP [16]. It has been termed an ‘energy sensor’ or ‘intracellular
fuel gauge’, becoming activated as ATP concentrations fall, and AMP
(and ADP) concentrations rise. AMPK is activated by phosphorylation of
AMPKα(Thr172), and decreases rates of anabolic processes (e.g. protein
synthesis) whilst increasing rates of catabolic processes (e.g. lipolysis).
Activation of AMPK by H2O2 in cardiomyocytes was assessed by im-
munoblotting of extracts for AMPKα(Thr172) phosphorylation. As in
other cells [29], AMPKα(Thr172) was rapidly phosphorylated in re-
sponse to 1mM H2O2 (maximal within 3–5min) (Fig. 2A) and the
concentration-dependence was such that activation was detectable at
0.3 mM H2O2 and plateaued at 1mM H2O2 (Fig. 2B).
mTORC1 regulates protein synthesis [17,18]. Raptor is a key reg-
ulatory subunit of mTORC1, and AMPK phosphorylates Raptor(Ser792),
causing it to dissociate from mTORC1, thus inhibiting mTORC1 ac-
tivity. Consistent with activation of AMPK, H2O2 increased phosphor-
ylation of Raptor(Ser792) (Fig. 2A). This was delayed relative to AMPK
activation, but the dependence on H2O2 concentration was similar
(Fig. 2B). Compound C is an AMPK inhibitor, though it inhibits a
number of other protein kinases [30]. SU6656 was originally identiﬁed
as an inhibitor of the protein Tyr-kinase Src [31], but inhibits a number
of other protein Ser-/Thr- kinases including AMPK [30]. Both com-
pound C (60 μM) and SU6656 (15 nM) inhibited phosphorylation of
Raptor(Ser792) induced in cardiomyocytes by H2O2 (1mM, 10min)
(Fig. 2C). We conclude that H2O2 reduces cardiomyocyte ATP con-
centrations and this activates AMPK leading to phosphorylation of
Raptor(Ser792). This is consistent with inhibition of protein synthesis
(Fig. 1C).
3.3. H2O2 induces PKB/Akt and mTOR phosphorylation
mTOR, the protein kinase component of mTORC1, is itself phos-
phorylated at several sites including mTOR(Ser2448) and mTOR
(Ser2481). mTOR(Ser2448) phosphorylation probably represents a
downstream ‘feedback’ phosphorylation whereas mTOR(Ser2481) phos-
phorylation is an autophosphorylation that occurs when mTOR is ac-
tivated [32,33]. In cardiomyocytes, phosphorylation of both sites was
increased by low concentrations of H2O2 (0.03–0.2 mM), whereas
higher concentrations (1–10mM) reduced mTOR phosphorylation
(Fig. 3A and B). Canonically, mTOR is activated by PKB/Akt [17,18].
PKB/Akt is phosphorylated on Thr308 in its catalytic domain and this is
required for mTOR activation. It is also phosphorylated on Ser473 in its
C-terminal hydrophobic domain with phosphorylation of both residues
probably necessary for maximal activation [34]. Concentrations of
H2O2 > 0.3mM resulted in phosphorylation of both PKB/Akt(Thr308)
and PKB/Akt(Ser473) (Fig. 3C). This should ultimately induce phos-
phorylation of mTOR(Ser2448) and mTOR(Ser2481), but there was no
correlation with these phosphorylations (Fig. 3A and B). This implies
that a supervening intervention, presumably by phosphorylation of
AMPK and Raptor (Fig. 2A–C), interferes with PKB/Akt-mediated
phosphorylation of mTOR(Ser2448) and mTOR(Ser2481).
3.4. Redox signalling vs. stress and expression of IEGs
Expression of IEG mRNAs is driven by pre-existing transcription
factors and de novo protein synthesis is not required [35]. This is
characterised by an increase in mRNA expression in the presence of
protein synthesis inhibitors such as cycloheximide. Indeed, because
cycloheximide exerts an additional stress on the cell, IEG mRNAs are
often superinduced. Many IEGs encode transcription factors which are
required for expression of ‘later-phase’ genes and expression of these
does require protein synthesis [36]. It may therefore be expected that
high concentrations of H2O2 that inhibit protein synthesis do not aﬀect
IEG mRNAs but suppress expression of later-phase mRNAs. Jun, Atf3
and Egr1 are well-established IEGs. All were upregulated in cardio-
myocytes exposed to 0.3 mM H2O2 (2 h) and this was enhanced by the
protein synthesis inhibitor cycloheximide (Fig. 4A), conﬁrming they are
IEGs. As expected, these mRNAs were still upregulated by 1mM H2O2, a
concentration that substantially inhibits protein synthesis (Fig. 1C),
although upregulation was delayed relative to 0.3mM H2O2 (Fig. 4B).
In contrast, upregulation of Nqo1 and Hmox1 by 0.3 mM H2O2 was
inhibited by cycloximide (Fig. 4C), conﬁrming they are later phase
genes. These mRNAs were not signiﬁcantly upregulated by 1mM H2O2
(Fig. 4D). Our previous work identiﬁed Mdm2 and Cdkn1a as genes
which were signiﬁcantly upregulated by low, sub-toxic concentrations
of H2O2 (0.04mM) [12] and we subsequently showed that Mdm2 is
cytoprotective under conditions of oxidative stress. [37]. Experiments
with cycloheximide indicate that Mdm2 and Cdkn1a were both upre-
gulated as IEGs (Fig. 4E). Consistent with this, they were both upre-
gulated by a high concentration of H2O2 (1mM), albeit with some delay
relative to 0.3 mM H2O2 (Fig. 4F) as was seen with Jun, Atf3 and Egr1
(Fig. 4B).
3.5. Polysomal proﬁling of mRNA transcripts
Even though moderate concentrations of H2O2 (0.1–0.3 mM) did not
suppress global protein synthesis to any signiﬁcant extent (Fig. 1C), the
substantial eﬀect on ATP concentrations (Fig. 1A) could aﬀect synthesis
of speciﬁc proteins. We therefore examined recruitment of mRNAs to
cardiomyocyte polysomes following exposure to 0.2 mM H2O2 (1 h)
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Fig. 1. H2O2 reduces ATP levels and inhibits protein synthesis in cardiomyo-
cytes. Cardiomyocytes were exposed to the concentrations of H2O2 shown for
the times indicated. (A) Concentrations of ATP were measured using a luci-
ferase assay. Results are % of control values and are means± SEM (n=4 in-
dependent myocyte preparations). (B) Area under curve (AUC) analysis of
cardiomyocyte ATP levels from the data in (A). ***p < .001 relative to control
(one-way ANOVA with Tukey post-test). (C) Protein synthesis was measured by
incorporation of [3H]-Phe. Results are means± SEM (n=4 independent
myocyte preparations). The IC50 was calculated using the 4-step parameter
function in GraphPad Prism 7. ***p < .001, ****p < .0001 relative to 0.1 mM
H2O2 (one-way ANOVA with Tukey post-test).
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using Aﬀymetrix microarrays for global transcriptomic proﬁling. At this
early time, 26 probesets (18 established protein-coding mRNAs) were
signiﬁcantly downregulated with 238 probesets (162 established pro-
tein-coding mRNAs) signiﬁcantly upregulated (> 1.5-fold change,
p < .05 FDR) in either the total or polysomal pool (Fig. 5A; Supple-
mental Spreadsheet 1). Of the upregulated mRNAs, 144 (e.g. Atf3, Jun,
Hmox1) were not diﬀerentially regulated in the total pool relative to the
polysomes (Supplemental Spreadsheet 1) with a strong positive corre-
lation between the relative upregulation in each of the mRNA pools
(Fig. 5B). However, the proﬁles were not entirely overlapping (Fig. 5C)
and 12 mRNA species (Anxa1, Egr1, Egr2, Egr3, Tp53inp1,Ereg, Hspa1,
Tacr2, Mdm2, Txnrd1, Isg20, and Cdkn1a) were upregulated to a sig-
niﬁcantly greater extent (> 1.5-fold; FDR < 0.05) in the total pool
relative to the polysomes suggesting that their polysomal recruitment
was reduced. In contrast, there was preferential recruitment of four
mRNA species (including Rasd1, Clk1, Nﬁl1 and Hist2h2aa3) to the
polysomes (Supplemental Spreadsheet 1). Others, such as Thbs1 were
diﬀerentially regulated, but the diﬀerence was either not statistically
signiﬁcant or below our 1.5-fold threshold. Examples of genes with
diﬀerential expression are shown in Fig. 5D. The data for Hmox1, Atf3,
Nﬁl1, Rasd1 and Mdm2 were validated by qPCR (Fig. 5E). Thus, even
though ATP concentrations were substantially reduced (Fig. 1A),
polysomal recruitment of ~90% of mRNA species was unaﬀected.
3.6. p21Cip1/WAF1 (the protein product of the Cdkn1a gene) induced by sub-
toxic H2O2 levels is cytoprotective
p21Cip1/WAF1 was identiﬁed as a cyclin-dependent kinase inhibitor
[38], but has other roles according its subcellular localisation [39,40].
Our previous microarray studies identiﬁed Cdkn1a as one of a small
group of genes that was upregulated in cardiomyocytes by subtoxic
concentrations of H2O2 [12], whilst here we have conﬁrmed it is an IEG
(Fig. 4E and F). However, the functional role of p21Cip1/WAF1 in cardi-
omyocytes is unknown. Cdkn1a mRNA was similarly upregulated in
total and polysomal RNA pools (Fig. 5D), indicating that it is likely to be
translated. Consistent with this, p21Cip1/WAF1 protein was rapidly in-
creased in cardiomyocytes exposed to 0.2mM H2O2 with maximal ex-
pression from ~2 h that was sustained up to at least 24 h (Fig. 6A).
p21Cip1/WAF1 protein was detected in both nuclear and cytosolic extracts
from ~90min (Fig. 6B). Interestingly, the concentration-dependency of
the response was bell-shaped and p21CIP1/WAF1 was not induced by
0.5 mM H2O2 at 2 h (Fig. 6C). This presumably reﬂects the reduced rate
of protein synthesis (Fig. 1C).
To determine if p21Cip1/WAF1 is cytoprotective in cardiomyocytes,
Fig. 2. H2O2 activates AMPK and promotes AMPK-dependent phosphorylation of Raptor. Cardiomyocytes were exposed to 1mM H2O2 for the times shown (A), to the
concentrations of H2O2 indicated for 5min (B), or were treated with SU6656 (15 nM) or compound C (60 μM) prior to addition of H2O2 (1mM; 10 mins) (C). Samples
were immunoblotted with antibodies to phosphorylated (P)-AMPKα(Thr172), total AMPKα, P-Raptor(Ser792) or total Raptor as indicated. Representative blots are
shown in the left panels, with densitometric analysis and the ratio of Phospho−/Total proteins in the graphs on the right. (A) and (B), Results are means± SEM
(n=4 independent myocyte preparations). *p < .05, **p < .01, ***p < .001 relative to unstimulated cells (one-way ANOVA with Dunnett's post-test). (C) Results
are means± SEM (n=3 independent myocyte preparations). ****p < .0001 relative to unstimulated cells, #### p < .0001 relative to H2O2 alone (one-way
ANOVA with Bonferroni post-test).
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cardiomyocytes were transfected with Cdkn1a antisense oligonucleo-
tides (Cdkn1a-AS-ODN) to suppress p21Cip1/WAF1 protein expression or
a scrambled version of the Cdkn1a-AS-ODN (Cdkn1a-Scr-ODNs). As
expected, Cdkn1a AS-ODN accumulated in the nucleus (not shown).
H2O2 (0.2 mM, 4 h) increased expression of p21Cip1/WAF1 protein in
transfected cells (Fig. 6C). This was signiﬁcantly inhibited by Cdkn1a-
AS-ODN (52 ± 4.6% relative to H2O2 alone, p < .01) but not by
Cdkn1a-Scr-ODN. We demonstrated that 0.2 mM H2O2 induces apop-
tosis in neonatal rat cardiomyocytes as assessed by loss of mitochon-
drial membrane potential, TUNEL analysis and immunoblotting for
cleaved caspase 3 [37], with detection of cleaved caspase 3 being
probably the most reliable marker of cell death for quantiﬁcaiton pur-
poses [44]. The reduction in p21Cip1/WAF1 protein by Cdkn1a-AS-ODN
in the context of H2O2 stimulation enhanced the amount of cleaved
caspase 3, indicative of increased apoptosis (Fig. 6C). The anthracyclin
doxorubicin is an anti-cancer agent that is cardiotoxic and increases
ROS generation and promotes cardiac oxidative stress [41]. Doxor-
ubicin increased expression of p21Cip1/WAF1 protein over 3–4 h
(Fig. 6D). As with H2O2, this was signiﬁcantly inhibited by Cdkn1a-AS-
ODN but not by Cdkn1a-Scr-ODN, and decreased expression of p21Cip1/
WAF1 protein was associated with enhanced appearance of cleaved
caspase 3 and, thus, apoptosis (Fig. 6E). Hence, p21Cip1/WAF1 is
cytoprotective in the cardiomyocyte response to redox/anthracycline
stress.
3.7. mTOR regulates expression of p21Cip1/WAF1
mTOR is phosphorylated in cardiomyocytes exposed to moderate
levels of H2O2 (0.1–0.3mM) (Fig. 3A and B), indicative of its activation.
The pan-mTOR inhibitor KU63794 [42] and mTORC1 inhibitor rapa-
mycin almost completely prevented p21Cip1/WAF1 expression in the
nuclear fraction (Fig. 7A) but had no eﬀect on its expression in the
cytoplasmic fraction (Fig. 7B). This was associated with increased
caspase-3 cleavage (5.76 ± 0.9 fold) (Fig. 7C). Thus, mTOR is required
for cytoprotection in the context of low levels of redox stress, in part by
increasing expression of cytoprotective proteins such as p21Cip1/WAF1.
4. Discussion
Redox levels exert pleiotropic eﬀects on cellular responses, ranging
from promotion of cell survival through to regulation of cell death.
Perhaps unsurprisingly, therefore, redox stress underlies a plethora of
disease states including heart failure. Understanding how ROS signal-
ling can elicit such a panoply of responses is of crucial importance for
Fig. 3. H2O2 (0.03–0.3 mM) activates mTOR but concentrations > 1mM are required for activation of PKB/Akt. Cardiomyocytes were exposed to the concentrations
of H2O2 indicated for 15min (A) and (C), or to 0.2mM H2O2 for the times shown (B). Samples were immunoblotted with antibodies to phosphorylated (P)-mTOR
(Ser2448), P-mTOR(Ser2481), total mTOR, P-PKB/Akt(Ser473), P-PKB/Akt(Thr308) or total PKB/Akt as indicated. Representative blots are shown in the panels on the
left, with densitometric analysis and the ratio of Phospho−/Total proteins in the graphs on the right. Results are means± SEM [n=4 (A) and (B) or n=3 (C)
independent myocyte preparations]. *p < .05, **p < .01 and ***p < .001 relative to unstimulated cells (one-way ANOVA with Dunnett's post-test).
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the development of novel therapies for these diseases. Various hy-
potheses have been developed to explain the variation of responses,
including eﬀects of diﬀerent forms of ROS [21] and localised ROS
production for redox signalling (e.g. from NADPH oxidases or mi-
tochondria [9–11]). Whilst these factors clearly play a role, we assessed
a more fundamental hypothesis that the level of ROS per se is a key
factor in the cellular response, focusing on the AMPK-mTOR signalling
axis, regulation of protein synthesis and cell death. We demonstrated
the presence of a “redox rheostat” in which lower levels of ROS activate
mTOR with production of cytoprotective proteins such as p21Cip1/WAF1,
whilst higher levels cause a reduction in ATP with activation of AMPK,
inhibition of protein synthesis and cell death (Fig. 7D). We propose that
a sliding scale operates between these extremes, with variation in
production of antioxidants and cytoprotective proteins balanced against
ATP levels. This accounts for whether cells survive or grow and, if the
balance is in favour of cell death, the mode of cell death in which highly
regulated apoptosis will proceed if ATP levels suﬃce, but necrotic cell
death occurs if there is catastrophic loss of ATP [43].
The relationship between intracellular ATP concentrations, and
AMPK-mTOR signalling in relation to protein synthesis is clearly
Fig. 4. H2O2 upregulates immediate early genes, but not second-phase gene products. (A), (C) and (E) Cardiomyocytes were exposed to 0.2 mM H2O2 for 2 h in the
absence or presence of 20 μM cycloheximide (CHX). (B), (D) and (F) Cardiomyocytes were exposed to 0.3 mM or 1mM H2O2 for the times indicated. mRNA
expression was measured by qPCR. Results are means± SEM (n=4–6 independent myocyte preparations). (A), (C) and (E) *p < .05, **p < .01 and ***p < .001
relative to unstimulated controls, # p < .05 relative to H2O2 alone (one-way ANOVA with Tukey post-test). (B), (D) and (F) *p < .05, **p < .01 and ***p < .001
relative to unstimulated controls, # p < .05 relative to 0.3 mM H2O2 (one-way ANOVA with Tukey post-test).
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complex. Whilst it may seem obvious that declining ATP concentrations
should be associated with inhibition of protein synthesis, the con-
centration-dependencies did not overlap fully, with substantial loss in
global ATP at concentrations that did not appear to impinge on global
protein synthesis (Fig. 1). Instead, signiﬁcant inhibition of protein
synthesis occurred at concentrations ≥1mM H2O2, that are highly
toxic to cardiomyocytes [44], and we suggest this represents complete
shutdown of cellular processes whilst striving for survival. The me-
chanism most likely involves AMPK phosphorylation of Raptor(Ser792),
a mechanism shown in other systems to inhibit global protein synthesis
via inhibition of mTORC1 [15–18], since the concentrations of H2O2
required to promote phosphorylation of AMPKα(Thr172) and Raptor
Fig. 5. Recruitment of mRNAs induced by H2O2 to polysomes for translation. Cardiomyocytes were unstimulated (Control) or exposed to 0.2 mM H2O2 (1 h) and total
or polysomal RNA prepared for microarray analysis [(A) - (D)] or qPCR (E). (A) Heatmap (Log2 scale) of all probesets with signiﬁcantly decreased or increased
expression (> 1.5-Fold change; FDR < 0.05) in total or polysomal RNA fractions. Expression values were normalised to the gene median. (B) Relative fold change of
upregulated mRNAs in polysomal vs total RNA pools. Linear regression analysis indicates that most mRNAs are regulated similarly in total and polysomal fractions
and are translated eﬃciently. (C) Overlay plot of mRNAs induced by H2O2 in total and polysomal RNA pools to show diﬀerential changes in some genes. (D) Heatmap
(Log2 scale) of speciﬁc genes relevant to this study is shown on the left, with fold change relative to controls on the right. (E) qPCR validation of microarray data
showing similar changes in expression in total or polysomal RNA fractions for Hmox1 and Atf3, enhanced recruitment of Nﬁl3 and Rasd1 to polysomes for translation
and less eﬃcient recruitment ofMdm2 to polysomes. Results are means± SEM (n=4 independent myocyte preparations; these are diﬀerent preparations from those
used for microarray analysis). *p < .05, ***p < .001 relative to unstimulated controls, # p < .05 relative to fold-change in total RNA pool (one-way ANOVA with
Tukey post-test).
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(Ser792) (Fig. 2B) were those that caused inhibition of protein synthesis
(Fig. 1C). Classically, mTOR (and therefore mTORC1) is activated by
PKB/Akt [17,18], and we have shown previously that H2O2 activates
PKB/Akt, increasing phosphorylation of both Thr308 and Ser473 [20].
Here, as before [20], PKB/Akt was only signiﬁcantly phosphorylated on
both residues with>1mM H2O2 (Fig. 3C), concentrations that appear
incompatible with protein synthesis (Fig. 1C). Our previous work
identiﬁed an over-riding phosphatase activity causing
Fig. 6. H2O2 or doxorubicin increase p21Cip1/WAF1 protein in cardiomyocytes to reduce apoptosis. (A) and (B) Cardiomyocytes were exposed to 0.2 mM H2O2 [(A) and
(B)] or to 0.4 mM doxorubicin (E) for the times indicated and total extracts [(A) and (D)] or nuclear and cytosolic extracts (B) immunoblotted with antibodies to
p21Cip1/WAF1. Representative immunoblots of at least 4 independent experiments are shown. Densitometric analysis is included to the right panels (A) and (D).
Results are means± SEM (n=4 independent myocyte preparations). *p < .05, **p < .01 relative to unstimulated cells (one-way ANOVA with Dunnett's post-test).
(C) Cardiomyocytes were exposed to the concentrations of H2O2 indicated for 120min and immunoblotted with antibodies to to p21Cip1/WAF1. Densitometric analysis
is included below the panel. Results are means± SEM (n=4 independent myocyte preparations). *p < .05, ****p < .0001 relative to unstimulated cells (one-way
ANOVA with Dunnett's post-test). (D) and (F), Cardiomyocytes were exposed to 0.2 mM H2O2 (4 h) or 0.4 mM doxorubicin (4 h) alone (Control), following treatment
with transfection reagent without oligodeoxynucleotides (no ODN) or following transfection with antisense ODNs (AS-ODNs) for Cdkn1a or scrambled ODNs (Scr-
ODNs). Samples were immunoblotted with antibodies to p21Cip1/WAF1, cleaved caspase 3 or the loading control sarcomeric α-actin. Representative immunoblots are
shown on the left, with densitometric analysis on the right. Data are means± SEM (n=6 independent myocyte preparations). *p < .05, ****p < .0001 relative to
vehicle, #p < .01 relative to H2O2 treated cells with no ODNs, @ p < .05 relative to Cdkn1a-AS-ODN (two-way ANOVA with Tukey post-test).
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dephosphorylation of 4E-BP1 to reduce availability of eIF4E for initia-
tion of translation [20]. Here, the data suggest there is an additional
mechanism with inhibition of mTOR via AMPK-dependent phosphor-
ylation of Raptor(Ser792) (Fig. 2).
Whilst high concentrations of H2O2 inhibited mTORC1 and global
protein synthesis, our data indicated that lower concentrations were
associated with increased phosphorylation of mTOR(Ser2448) and
mTOR(Ser2481) (Fig. 3A). The mechanism is unclear since we did not
detect signiﬁcant increases in PKB/Akt phosphorylation at these
concentrations (Fig. 3C). This was not associated with a signiﬁcant
increase in global protein synthesis (Fig. 1C), but lower concentrations
were associated with diﬀerential recruitment of some mRNAs to the
polysomes of cardiomyocytes with enhanced recruitment (and there-
fore increased eﬃciency of translation) of some (e.g. Nﬁl3, Rasd1) and
reduced eﬃciency of others (e.g. Mdm2) (Fig. 5). Indeed, these data are
consistent with studies in brain in which focal ischaemia (associated
with increased oxidative stress) results in selective recruitment of
transcripts to the polysomes for translation [45]. As in the brain, and in
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contrast to insulin treatment of cardiomyocytes [24], we did not detect
selective recruitment of transcripts with 5′ terminal oligopyrimidine
tracts (TOPs) that are classically recruited following activation of p70
ribosomal S6 kinase via mTORC1.
The AMPK-mTOR axis is intimately linked to regulation of protein
synthesis. However, the rate of global protein synthesis has a signiﬁcant
impact on expression of certain transcripts, namely those which require
de novo synthesis of the transcription factors that regulate their ex-
pression. The concept of IEGs derived from early work on viral gene
expression, but was extended to mammalian genes in which IEGs were
deﬁned as those for which transcription requires only pre-existing
transcription factors [35]. This means that protein synthesis is not re-
quired, and inhibiting protein synthesis with, for example, cyclohex-
imide, or H2O2 did not abolish upregulation of classic IEG mRNAs in-
cluding Jun, Atf3 and Egr1 (Fig. 4A and B), although the rate of increase
was delayed with 1mM H2O2, possibly a reﬂection of the low energy
status of the cells. These and many other IEGs encode transcription
factors required for expression of later phase non-IEGs including
Hmox1, and Nqo1, so if protein synthesis is inhibited and IEG mRNAs
are not translated, these later phase genes are not upregulated even at
the mRNA level. This was clearly apparent and upregulation of Hmox1
and Nqo1 mRNAs was abolished by cycloheximide or 1mM H2O2
(Fig. 4C and D). These mRNAs along with other non-IEGs (e.g. Gclc,
Txnrd1, Srxn1) form part of the neutralising response to an oxidant
load, so inhibition of expression of these genes is likely to compromise
cellular defences further, exacerbating the eﬀects of high levels of redox
stress and hasten progression to cell death.
This study, together with our previous microarray studies [12],
identiﬁed a number of genes that are classically regulated by p53 in-
cluding Mdm2 and Cdkn1a (encoding p21Cip1/WAF1 protein). We have
already reported that upregulation of Mdm2 mRNA by H2O2 did not
appear to require de novo synthesis of p53, with it being regulated by
AP-1 transcription factors [37]. Here, we show that both Mdm2 and
Cdkn1a are upregulated by moderate concentrations of H2O2 (0.2 mM)
in cardiomyocytes as IEGs (Fig. 4E and F). p21Cip1/WAF1 protein ex-
pression induced by 0.2mM H2O2 was sustained over 2–24 h (Fig. 6A
and B) and, as with Mdm2 [37], preventing protein expression with
antisense ODNs enhanced the rate of apoptosis shown by caspase-3
cleavage [37,44] (Fig. 6C), indicating that it is also a cytoprotective
protein. This is consistent with a recent report in which p21Cip1WAF1
was shown to protect H9c2 cells (a cardiomyocyte-like cell line) in a
simulated ischaemia-reperfusion injury model [46]. A role for
p21Cip1WAF1 in cardiomyocyte cytoprotection is also consistent with
reports in other cells in which the protective eﬀect is attributed to ac-
cumulation in the cytoplasm rather than the nucleus [47]. In lung
adenocarcinoma cells [48,49], cytosolic p21Cip1WAFf1 suppresses mi-
tochondrial cell death pathways, including caspase-3 activation by
preserving anti-apoptotic Bcl-2 family members. Based on our ﬁndings
and previous work, we rationalise that the role for cytosolic p21Cip1/
WAF1 in myocytes is to inhibit mitochondrial death pathways given that
oxidative stress negatively alters Bcl-2 signalling [44], leading to car-
diac myocyte apoptosis. However, p21Cip1/WAF1 was detected in both
myocyte compartments (Fig. 6B), suggesting that it has an additional
role in the nucleus even in terminally-diﬀerentiated post-mitotic cells.
Interestingly, inhibition of mTOR with KU63794 or rapamycin partially
inhibited the increase in p21Cip1/WAF1 protein induced by 0.2 mM H2O2,
but inhibition was preferentially targeted to the nuclear compartment,
with relative preservation of the protein in the cytoplasm (Fig. 7A and
B). Nevertheless, both KU63794 and rapamycin enhanced the rate of
cardiomyocyte apoptosis induced by 0.2 mM H2O2.
Our data here indicate that p21CIP1/WAF1 is protective in cardio-
myocytes exposed to 0.2mM H2O2, and previously we have shown that
Mdm2 also contributes to cytoprotection [37]. Nevertheless, cardio-
myocytes still undergo apoptosis under these conditions as we have
shown previously [44], indicating that the presence of these proteins is
not suﬃcient for complete protection and raising the question of the
importance of their upregulation. One consideration is that some de-
gree of cytoprotection may be required to ensure that cell death pro-
ceeds via regulated programmed cell death and loss of protective ele-
ments such as expression of p21CIP1/WAF1 and Mdm2 may increase the
probability of non-regulated cell death (i.e. necrosis with associated
inﬂammation). Another consideration is that we all study an entire
population of cells and, for this study, each sample was prepared from 4
million cardiomyocytes. There is undoubtedly a spectrum of response
and we measure the average. We simply do not know (and do not have
the ability to assess) if these proteins are expressed only in a sub-
population of surviving cells. At higher concentrations of H2O2, protein
synthesis is suppressed and, even though mRNAs increase, protein ex-
pression is compromised. Consistent with this, the concentration-de-
pendency for expression of p21CIP1/WAF1 protein is bell-shaped with
little induction of protein at 0.5mM at 2 h (Fig. 6C). It remains to be
established whether forced expression of proteins such as p21CIP1/WAF1
and Mdm2 would confer cytoprotection under conditions of high level
ROS, when cellular metabolism is compromised.
In summary, we present data to support a novel concept of the
cardiomyocyte “redox rheostat” in which diﬀerent degrees of ROS
stress inﬂuence cell energetics and intracellular signalling pathways to
regulate mRNA and protein expression. This sliding scale of responses
determines cell fate, modulating cell survival vs cell death.
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